series-a
Stage
2
Investors
About
Universal DX is a molecular diagnostics company developing non-invasive blood tests for early cancer detection. Their flagship product, Signal-C, is a liquid biopsy test for colorectal cancer screening.
Explore Universal DX's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.